Dyne commences Phase III HARMONIA trial for DM1 therapy
The trial aims to enrol 150 participants aged 16 years and above.
Clinical Trials
Aisa Pharma reports positive results for AISA-021
DiaMedica gains Health Canada approval for Phase II preeclampsia trial
Seqster unveils 1-Click DataLake for clinical trials
MIRA Pharmaceuticals completes dosing in Ketamir-2 Phase I trial
HUTCHMED begins Phase I/IIa trial of HMPL-A580 for solid tumours
Syntis Bio begins patient dosing in Phase I trial of SYNT-101 for obesity
Kyowa Kirin discontinues ongoing trials of rocatinlimab
